NVCT

Nuvectis Pharma (NVCT)

About Nuvectis Pharma (NVCT)

Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its product pipeline includes NXP800 and NXP900. The company was founded by Ronald E. Bentsur, Enrique Poradosu, and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.

Details

Daily high

$8.00

Daily low

$7.52

Price at open

$7.66

52 Week High

$11.52

52 Week Low

$4.44

Market cap

194.2M

Dividend yield

0.00%

Volume

54,244

Avg. volume

93,043

P/E ratio

-5.74

Nuvectis Pharma News